Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 30, 2025
AAV-mediated expression of a new conformational anti-aggregated α-synuclein antibody prolongs survival in a genetic model of α-synucleinopathies.
Journal: NPJ Parkinson's disease
Published: December 02, 2022
BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies.
Journal: The Journal of pharmacology and experimental therapeutics
Published: October 11, 2022
Sema3A Antibody BI-X Prevents Cell Permeability and Cytoskeletal Collapse in HRMECs and Increases Tip Cell Density in Mouse Oxygen-Induced Retinopathy.
Journal: Translational vision science & technology
Published: June 21, 2022
Ocular and systemic pharmacokinetics of BI-X, a nanobody targeting VEGF and Ang-2, after intravitreal dosing in cynomolgus monkeys - Evidence for half-life extension by albumin.
Journal: Experimental eye research
Published: October 23, 2020
VHH antibody targeting the chemokine receptor CX3CR1 inhibits progression of atherosclerosis.
Journal: mAbs
Published: January 12, 2020
Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodies.
Journal: Biochemical and biophysical research communications
Published: August 03, 2018
Docosahexaenoic acid supplementation, vascular function and risk factors for cardiovascular disease: a randomized controlled trial in young adults.
Journal: Journal of the American Heart Association
Published: July 03, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026